Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Compare which total market fund to hold in retirement in 2024 and how to balance it with other assets. Focus on cost, tax efficiency, and diversification.
28,509 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Regulators in the UK are turning up the heat on crypto perpetual contracts. The latest wave centers on Hyperliquid an...
Investors often chase Berkshire Hathaway's stock picks, but the real driver of lasting success is the company’s opera...
A troubling trend is rising where criminals recruit ordinary people through Telegram to intercept high-value deliveri...
As quantum tech moves from lab to real-world use, two stocks stand out for 2026. This guide explains why IonQ and IBM...
Viking isn’t just another cruise line on the stock market. This article breaks down five reasons reasons Viking diffe...
A new survey of 351 institutions finds 25% intend to add XRP in 2026, joining the 18% already holding the token. Pric...
SpaceX is advancing toward an IPO in mid-June. This guide breaks down what the S-1 reveals, how to assess risk, and p...
A niche corner of the tech market has seen attention turn toward optical component makers. This article explains why ...
GE Aerospace delivered strong results in 2026, but the broader XLI index outpaced the stock through July. Here's what...
Investors are weighing Hut 8 and Riot Platforms as data-center developers expanding beyond Bitcoin mining. This guide...
With Johnson & Johnson stock hovering near mid-230s, investors are weighing if a $300 target is in reach this year as...